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Abstract
Breast cancer is the second leading cause of cancer-related deaths among women in the 
United States, and most of these deaths are due to metastasis to a secondary site, which is 
primarily the skeleton. The connection between primary breast cancer and frequent bone 
metastasis is poorly understood. Here, 1 investigate the role of two features of the bone 
microenvironment that may help elucidate this connection, the presence of mineral and 
mechanical stimuli. Bone marrow-derived mesenchymal stem cells (BM-MSCs) cultured with 
tumor-secreted soluble factors from bone-specific metastatic breast cancer cells deposited more 
mineral relative to factors from primary and lung-specific breast cancer cells, which could 
potentially explain the source of microcalcifications in the primary breast tumor. Additionally, I 
developed an in vitro loading system utilizing a mineralized 3-D model of the bone 
microenvironment. In the absence of loading, BM-MSCs in hydroxyapatite-containing (HA) 
scaffolds demonstrated enhanced osteoblastic activity compared to those in non-mineral- 
containing control scaffolds. Under compressive loading, BM-MSCs cultured with tumor- 
secreted soluble factors exhibited early commitment to the osteoblastic lineage. Loading did not 
affect breast cancer cell viability in this system, but expression of Runx2, a regulator of secretion 
of osteolytic proteins, was decreased 35% with loading. Taken together, these results suggest that 
bone marrow-derived stem cells are the source of microcalcifications, and metastatic tumor cells 
may affect the ‘vicious cycle’ by modulating the activity of osteoblasts and osteoclasts.
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Introduction
Breast cancer is the second leading cause of cancer-related deaths among women in the 
United States, and most of these deaths are due to metastasis to a secondary site, which is 
primarily the skeleton1,2. Metastatic bone disease increases patient morbidity and mortality by 
promoting hypercalcaemia, spinal instability, pain, and bone fragility and fracture3'5. The link 
between primary breast cancer and its predilection for metastasizing to the skeleton is poorly 
understood. Here, I investigate the role of two unique facets of the bone microenvironment that 
may provide a favorable milieu for metastatic cells, the presence of mineral and mechanical 
stimuli. Firstly, microcalcifications in breast tissue share characteristics similar to mineral 
crystals in the skeleton, and they may be formed by stem cells recruited from the bone marrow6. 
Interactions between these microcalcifications and primary tumor cells may help drive metastasis 
to bone. Secondly, once these metastatic cells reach the skeleton, they exploit the bone 
remodeling process, but the effects of mechanical signaling in the metastatic niche may confer 
some protection against secondary tumor growth.
Breast microcalcifications, or the formation of calcified substrate within mammary tissue, 
have been linked to promotion of metastasis7. Clinically, they are used as a diagnostic marker for 
breast cancer8 and the degree of malignancy has been correlated with the specific type of 
microcalcification9. In particular, hydroxyapatite (HA), the prevalent inorganic mineral of the 
skeletal matrix, has been specifically associated with more malignant forms of breast cancer7,8. 
Yet, the formation of microcalcifications, the molecular effects of microcalcification-breast 
cancer interactions, and their link in promoting bone metastasis remain poorly understood. Here, 
I hypothesized that bone marrow-derived mesenchymal stem cells (BM-MSCs) are the primary
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source of breast microcalcifications and I examined the effects of tumor-secreted soluble factors
on mineralization by BM-MSCs.
Mechanical stimuli in the skeleton plays a large role in regulating the process by which 
bone mass is maintained10. In healthy individuals, the homeostatic bone remodeling process 
includes degradation of the skeletal matrix by osteoclasts followed by new organic matrix being 
laid down by osteoblasts. However, in the presence of tumor cells, the relative activities of these 
two bone cells are dysregulated. In the ‘vicious cycle’ of bone metastasis, tumor-secreted soluble 
factors increase osteoclast-mediated osteolytic activity, which releases pro-tumorigenic factors 
from the skeletal matrix, ultimately favoring tumor settlement and growth11. This cycle leads to 
bone loss and high risk for fracture. Increased mechanical loading results in net bone formation 
by increasing osteoblastic activity1213 and physical activity is currently an approach for treating 
other forms of bone loss, such as osteoporosis14. Physical exercise could also potentially serve as 
an adjuvant therapy for bone metastasis patients15,16. In fact, in vivo studies from our lab 
conducted by Dr. Maureen Lynch have shown that mechanical loading reduced secondary tumor 
growth and osteolytic degradation in tumor-bearing limbs through enhanced osteoblast activation 
and suppression of tumor-associated osteoclasts17, but whether or not loading directly affects 
tumor cells was not addressed by these previous studies. I hypothesized that mechanical loading 
would directly affect tumor cells, and have adapted a mineral-containing culture model so that I 
can apply mechanical loading in order to determine the role of loading in bone metastasis.
Materials and Methods
Characterization o f BM-MSC Microcalcifications
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To probe the genesis of breast microcalcification, I collected tumor-secreted soluble 
factors from primary, bone-metastatic, and lung-metastatic human breast cancer cells and 
observed their effects on bone marrow-derived mesenchymal stem cells (BM-MSCs) 
mineralization in two-dimensional (2-D) culture. To observe the effect of passage number on 
mineralization by BM-MSCs, the experiment was repeated using BM-MSCs at passage 4, 5, and 
6. Mineralization was measured both qualitatively and quantitatively by Alizarin red staining, 
which stains for calcium deposition. Osteogenic differentiation was measured by alkaline 
phosphatase (ALP) activity. Positive and negative controls, those with osteogenic differentiation- 
inducing factors (+) or basal media only (-), were included.
Development o f 3-D Mineralized Culture Model for BM-MSCs
To demonstrate the importance of mineral in creating a proper culture model of the bone 
microenvironment, Siddharth Pathi from our lab modified an established three-dimensional (3- 
D) in vitro scaffold system18 by incorporating HA, which tailors this system for modeling the 
bone microenvironment and secondary metastatic tumor growth19,20. I cultured BM-MSCs in 
these HA-containing scaffolds for 60 days to demonstrate that BM-MSCs differentiation into 
bone cells and thrive in this model. Control scaffolds were prepared similarly without HA. Each 
scaffold type was randomized into osteogenically-induced or non-induced groups. Osteogenic 
differentiation was measured by ALP activity, collagen and mineral deposition via histological 
analysis, and gene expression of osteocalcin, a noncollagenous bone matrix protein. 
Mineralization was also assessed by utilizing micro-computed tomography and measuring 
compressive moduli.
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Characterization o f Loading Effects in a 3-D Culture Model
To investigate the direct effect of mechanical loading on metastatic breast cancer cell 
behavior, I applied mechanical loading to scaffolds seeded with primary breast cancer cells. For 
the effect of loading on cancer cells, I looked at genes commonly associated with bone 
metastasis (OPN, MMP1, and CXCR4)21 or osteolysis (IL-8, RANK, DKK, Runx2)22'27 In 
breast cancer cells, aberrant Runx2 activity is associated with metastasis and may also be related 
to paracrine signaling to bone cells28. Additionally, to investigate if tumor-secreted factors 
interfered with the normal loading response of bone cells, I applied loading to BM-MSCs 
cultured in the presence of tumor cell-secreted factors. Expression of genes indicating osteoblast 
differentiation, Runx2 and osteocalcin ' , were quantified. Expression of SDF-1, a protein 
associated with recruitment of primary tumor cells to the skeleton and formation of the pre- 
metastatic niche33, was also quantified.
Cell Lines and Culture
Bone marrow-derived stem cells (Lonza) were maintained in growth media (MSCGM, 
Lonza). Osteogenesis of BM-MSCs was induced by supplementing growth media with: O.lmM 
dexamethasone, 50mM ascorbic acid-2-phosphate, and 1M ^-glycerophosphate (Sigma). 
Cultures that had these supplements are hitherto referred to as ‘induced’ conditions; their 
corresponding controls ‘non-induced.’ Primary human metastatic breast cancer cells (MDA- 
MB231, 231, ATCC), and bone- (MDA-MB231-2287, 2287) and lung-specific (MDA-MB231- 
4175, 4175) subpopulations were maintained in complete Dulbecco’s Modified Eagle Medium 
(cDMEM, DMEM [Invitrogen] supplemented with 10% fetal bovine serum [FBS, Tissue Culture 
Biologicals] and 1% penicillin/streptomycin [P/S, Invitrogen]). 2287 and 4175 are organ-specific
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breast cancer sub-lines provided by Dr. Joan Massague from Memorial Sloan-Kettering Cancer 
Center. All cell lines were cultured in 175cm2 tissue culture flasks under standard cell culture 
conditions (37°C, 5% CO2).
Preparation o f Tumor-Conditioned Media
Tumor-conditioned media (TCM) from breast cancer sublines (231, 2287, 4175) were 
collected to study the effects of tumor-secreted factors on BM-MSC-driven microcalcification. 
Briefly, cancer cells were cultured in 175 cm2 tissue culture flasks and maintained in cDMEM. 
24 hours prior to collecting media, media was changed to low serum media (DMEM with 1% 
FBS and 1% P/S). TCM was concentrated ten-fold using Amicon Ultra-15 Centrifugal Filter 
Units (Millipore), and normalized by cell number. Control media was prepared with low serum 
media in the same manner. Concentrated TCM was then further diluted to two-fold in osteogenic 
media (231+, 2287+ 4175+) or in basal media (231-).
Fabrication o f 3-D Hydroxyapatite-Containing (HA) Scaffolds
HA scaffolds were prepared from poly(lactide-co-glcolide) (PLG) and hydroxyapatite 
(HA) using previously established methods18,19. Briefly, 8 mg of PLG microspheres (average 
diameter 5-50 pm), 8 mg of HA particles (Sigma, average diameter of 200 nm), and 152 mg of 
NaCl particles (J.T. Baker, size 250-425 pm) were cold pressed (Carver Press) into disks (1 mm 
thick, 8.5 mm diameter). These disks were subsequently subjected to a gas-foaming/particulate 
leaching technique that resulted in surface exposure of the incorporated mineral20 (Fig. 1). PLG 
control scaffolds were prepared in the same manner without HA.
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Scaffolds were sterilized with 70% ethanol, washed 4 times with sterile phosphate 
buffered saline, and seeded with 1.5 million cells per scaffold as previously described19. Cell- 
seeded scaffolds were pre-incubated on an orbital shaker at standard cell culture conditions for 3 
days prior to differentiation or loading studies. Scaffolds were kept on the orbital shaker in 
between loading sessions. At the end of experiments, scaffolds were bifurcated and randomly 
assigned into groups for subsequent analysis (n=2-4/analysis).
A.
Fig. 1: Fabrication of HA scaffolds and PLG (control) scaffolds via a gas-foaming/particular 
leaching technique. (A) After leaching out NaCl, open pores allow seeded cells to interact with 
3-D matrices and form tissue. (B) Representative HA scaffolds stained for Alizarin red. HA 
scaffolds exhibit extensive surface exposure of incorporated HA both on the surface and inside 
the scaffolds (red), while control scaffolds do not (yellow). The resulting scaffolds are 
approximately 1 mm thick and 8.5 mm diameter.
BM-MSC Differentiation in 3-D Scaffolds
Alkaline phosphatase (ALP) activity (Thermo Scientific) was measured from cell lysates. 
ALP activity was normalized to either total protein (Bio-Rad Protein Assay, Bio-Rad) or DNA 
content (Quantifluor fluorescent dye, Promega). For histological analysis of protein deposition 
within the scaffolds, scaffolds were fixed for 1 hour, embedded in paraffin, and sectioned. 
Sections were stained with Masson’s trichrome to detect collagen and mineral formation. All 
sections were stained in batch simultaneously to avoid variations in histology. Histological 
images were captured using an Aperio Scanscope (Aperio Technologies) and collagen content 
was quantified using ImageJ with RGB threshold for blue (RSB NIH). To measure overall 
mineral content, scaffolds were scanned using quantitative micro-computed tomography 
(microCT, Xradia) at 12.6pm isotropic voxel resolution. Each scaffold was manually segmented, 
and bone volume fraction (BV/TV) was quantified by dividing the mineral volume within the 
scaffold (BV) and the total volume (TV). Stiffness and Young’s modulus were measured for HA 
scaffolds (Enduratec ELF 3200). Finally, scaffold contraction was measured.
3-D Mechanical Loading
Initially, cyclic hydrostatic pressure was applied to scaffolds via a hydraulic testing frame 
(MTS). Hydrostatic pressure was applied to cell-seeded scaffolds at 6MPa, 1Hz for 2 hours per 
day for 5 days in a custom-made pressure vessel set up34. This approach did not result in changes 
for any of our conditions and was deemed inappropriate for differentiating BM-MSCs into 
osteoblasts instead of chondrocytes34.
Therefore, I employed a mechanical loading system that applied compression directly to 
the scaffolds, inducing bone substrate deformation and fluid flow through the pores of the
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scaffold, stimuli that bone cells typically experience in vivo35. The loading platen of an 
established loading bioreactor was utilized for applying dynamic mechanical compression to 
scaffolds in a 24 well plate36. In brief, after cell seeding, all scaffolds were randomized into 
loaded or non-loaded groups. Scaffolds then underwent dynamic loading for 3 days using 
parameters previously reported to stimulate osteoblasts (1Hz, 10% peak amplitude with a static 
offset of 5%, 1 hour per day)37. Scaffolds were kept on an orbital shaker in between loading 
sessions. 24 hours after the final loading session, scaffolds were harvested for gene expression, 
DNA analysis, and live/dead staining. DNA was isolated using Caron’s buffer and was 
quantified using a Quantifluor fluorescent dye. Live cells were stained with calcein and dead 
cells were stained with propidium iodide.
RNA Extraction andRT-PCR
Gene expression was analyzed using quantitative RT-PCR (qPCR) and the comparative 
ACt method38. Briefly, mRNA was isolated using the TRIzol extraction method39 in RNase-free 
conditions. Quantitative PCR was performed using SYBR and primers of genes of interest and 
was normalized to the expression of P-actin (Supplementary Table 1).
Statistical Analysis
For the microcalcification study, the effect of TCM was compared between 2287 and 
other groups or 231 and other groups using one-way ANOVA. The effect of HA on ALP activity 
was compared between the experimental group and its corresponding control using one-way 
ANOVA. The effect of inducing factors was compared between the induced group and the non- 
induced group of each scaffold type separately using one-way ANOVA. The collagen content
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was compared using a Student’s t-Test. For the BM-MSCs differentiation study, experiments 
were performed in duplicate and results reflected pooled data. For in vitro loading, the effect of 
loading on gene expression was compared between the loaded and its corresponding non-loaded 
group using two-tailed t-tests. Experiments were carried out in duplicate and results reflected 
pooled data. Statistical significance (*) was set at p<0.05. All values are represented as mean ± 
SD.
Results
Tumor-Secreted Factors Increase BM-MSCs Differentiation in 2-D Culture
To observe to how breast cancer cells affect microcalcification formation by BM-MSC, 
the effect of tumor-secreted factors on BM-MSCs differentiation and mineralization was 
assessed. BM-MSCs were exposed to TCM from three different cancer cell sublines for two 
weeks. TCM with inducing factors collected from bone metastatic cells increased ALP activity 
the most relative to TCM from parental or lung metastatic cells (Fig. 2). No noticeable ALP 
activity was observed among cells cultured with basal media as well as cells cultured with 231 
TCM without inducing factors (231-). Mineral content was consistent with corresponding ALP 
expression. Mineral deposition was greatest from BM-MSCs treated with bone metastatic breast 
cell-secreted factors, followed by parental breast cancer cells, both qualitatively and 
quantitatively assessed via alizarin red staining (Fig. 3). Overall, no mineralization was observed 
without osteogenic inducing factors with the exception of lung metastatic breast cancer cells, 
which had similar values as both positive and negative controls.
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ALP Activity
Fig. 2: Normalized ALP activity in lysates prepared from BM-MSCs cultured with tumor- 
conditioned media from breast cancer cell sublines, and with/without osteogenic inducing factors 
(+, respectively). Compared to the control+ and control-, BM-MSCs with soluble factors from 
bone-specific cancer cells (2287+) had the highest levels of ALP activity. Those from parental 
(231+, 231-) and lung-specific cancer cells (4175+) had less ALP activity than those from 
2287+.
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Fig. 3: Mineralization in response to tumor-conditioned media. (A) Representative images of 
alizarin red staining for all tumor conditions and with/without osteogenic inducing factors (+, 
respectively). BM-MSCs cultured with both TCM and osteogenic factors deposited visible 
mineral, with the exception of the lung metastatic group (4175+). Scale = 500 pm (B) 
Quantification of alizarin red staining via stain extraction. Only bone-specific (2287+) and 
parental cancer cells (231+) showed significantly greater mineral content compared to the 
controls. *main effect of soluble factors from MB231+ (vs. other groups). # main effect of 
soluble factors from 2287+ (vs. other groups).
These results were consistent with previous studies done by a co-worker in our lab, but 
ALP activity and mineral were significantly lower, especially from the positive control group. 
Because the current studies were conducted with BM-MSCs at passage 6, while previous studies 
were with those at passage 4, I examined whether differentiation and mineralization was
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passage-dependent. ALP activity decreased from passage 4 to 5, and then increased from passage 
5 to 6 (Fig. 4). However, the pattern of relative ALP activity among the sublines was consistent 
within each passage and with the previous study, with the exception of ALP expression from 
lung metastatic cancer at passage 6, which expressed relatively low activity across all passages. 
Similar to ALP activity, mineral content as measured by Alizarin red staining decreased from 
passage 4 to 5, but increased at passage 6. On average, BM-MSCs cultured with parental and 
bone metastatic factors mineralized more than those with lung.
Fig. 4: Passage dependency of BM-MSCs differentiation and mineralization. (A) Normalized 
ALP activity decreased from passage 4 to 5, then increased at passage 6. The pattern -  2287+ 
having the greatest, following by controls -  was consistent among all the passages, except for 
lung metastatic at passage 6, which expressed relatively low activity across all passages. (B) 
Mineral content decreased from passage 4 to 5, then increased at passage 6. Relative values 
within each passage were consistent.
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HA-Containing Scaffolds Promote BM-MSCs Differentiation into Osteoblasts
Cells in 3-D culture form more natural cell-cell interactions and closely mimic tissues in 
vivo, so Siddharth Pathi from the Fischbach lab developed a 3-D culture model of the bone 
microenvironment. To study how effectively our scaffold system promotes the differentiation of 
BM-MSCs into mature osteoblasts, I seeded BM-MSCs into HA scaffolds or non-mineral- 
containing PLG scaffolds (control) and cultured them for 60 days. As expected, BM-MSCs 
cultured with osteogenic factors showed significantly elevated markers of osteoblast 
differentiation relative to control scaffolds. Non-induced cells in PLG scaffolds showed no ALP 
activity, while non-induced cells in HA scaffolds showed measurable ALP activity (Fig. 5). This 
result was further supported by collagen deposition. Induced cells in HA scaffolds showed the 
most collagen deposition both on the surface of and within scaffolds relative to all other groups 
(Fig. 6A, B). Similarly, gene expression for osteocalcin was also elevated for cells in induced 
HA scaffolds compared to control scaffolds.
ALP Activity
40-i *  # ■  Induced
Scaffold Type
Fig. 5: Normalized ALP activity in lysates prepared from BM-MSCs in HA and PLG (control) 
scaffolds via colorimetric assay analysis. Osteogenic inducing factors promoted significantly
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more ALP activity for BM-MSCs in both HA and control scaffolds, and the presence of HA in 
scaffolds further enhanced this response. #main effect of HA on ALP activity of BM-MSCs (vs. 
corresponding control scaffold), *main effect of osteogenic inducing factors on ALP activity of 
BM-MSCs (vs. corresponding non-induced group).
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Fig. 6: Protein deposition and osteocalcin gene expression following 60 days of osteogenic 
culture. (A) Representative image of scaffolds after Masson’s trichrome staining. BM-MSCs in 
induced HA scaffolds had the most collagen deposition (blue, represented by arrows) both on the 
surface and inside the scaffolds. Scale = 200 pm (B) % Area covered by collagen (blue) was 2- 
fold greater in induced HA scaffolds than in induced control scaffolds while collagen content did 
not change with induction in control scaffolds. (C) Osteocalcin gene expression was the greatest 
for cells in induced HA scaffolds. *HA induced vs. Control induced, # HA induced vs. HA non- 
induced.
To further quantify the amount of new bone formation by BM-MSCs in HA scaffolds, I 
measured total mineral content via microCT analysis. Induced HA scaffolds had greater BV/TV 
(160%) than those without osteogenic factors (Fig. 7B). Similarly, a trend was noted for greater 
compressive stiffness of HA scaffolds with osteogenic factors (Fig. 1C). The scaffolds with 
osteogenic factors deposited more minerals on the surface as well as inside than those without 
(Fig. 7A). Furthermore, both induced and non-induced HA scaffolds maintained their shape 
throughout 60 days, while both PLG types substantially contracted (Supplementary Fig. 1). 
Taken together, these results suggest that HA scaffolds not only provide a viable 3-D 
environment to the cells tested, but also a functional milieu in understanding cell-mineral 
interactions in the context of breast cancer bone metastasis19.
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Fig. 7: Influence of osteogenic factors on BM-MSC mineralization and stiffness. (A) 
Representative images of induced and non-induced (control) HA scaffolds taken following 60- 
day culture period. 3-D microCT images demonstrate that osteogenic factors resulted in greater 
mineral content. Bar = 1mm. (B) Bone volume fraction increased (160%) in the presence of 
osteogenic factors compared to the control (N=2 per condition). (C) Increased mineralization 
resulted in a trend for greater stiffness (N=3 per condition).
In Vitro Tumor Cell Response to Mechanical Loading
Dr. Lynch has previously shown that mechanical loading of mouse tibiae in vivo reduced 
cancer-mediated osteolysis17. To delineate the underlying mechanism of the loading-mediated 
bone homeostasis, I first studied the direct effect of loading on MDA-MB231 (MDAs) in HA
18
scaffolds. Prior to cell studies, Praveen Polamraju from the Fischbach lab determined the 
mechanical characteristics of the scaffolds to ensure that the mechanical loads that I applied were 
within the elastic range. To this end, Praveen measured the compressive Young’s modulus and 
yield strain of acellular HA scaffolds under quasi-static uniaxial compression, which were 
determined to be 290±20 kPa and 29±9% strain, respectively (Fig. 8A), indicating that 10% peak 
applied strain is well within the elastic range of the scaffolds. He also confirmed that our 
dynamic loading did not induce plastic strain hardening over time (data not shown). Following 3 
days of mechanical loading, MDA viability and proliferation were similar between loaded and 
nonloaded groups (Fig. 8C-D). Next, I examined the effect of mechanical loading on changes in 
expression of genes associated with metastasis. Interestingly, loading did not alter expression of 
bone metastasis-specific genes (OPN, MMP1, CXCR4)21 or genes associated with osteolysis (IL- 
8, RANK, DKK)22'27 (Table 1). However, expression of Runx2 was reduced 35% with loading 
(Fig. 8E). Runx2 is a transcription factor that is aberrantly expressed by tumor cells and is 
associated with their ability to cause osteolysis26,27. Runx2 also modulates production of proteins 
secreted by tumor cells, such PTHrP, that affect bone cell remodeling. Taken together, these 
results suggest that tumor cells are not directly affected by loading, but loading instead may 
modulate downstream effects on osteoblasts and osteoclasts.
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Fig. 8: (A) Representative stress vs. strain curve for HA scaffolds undergoing quasi-static 
mechanical compression. Young’s modulus and compressive strain of the scaffolds were 290+20 
kPa and 29+9% strain, respectively, ensuring that loading was performed in the linear elastic 
region of the HA scaffolds. (B) Loading platen used for loading MDA-MB231 tumor cell-seeded 
scaffolds in a 24 well plate for use in an established loading bioreactor36 (C) Representative 
image of live and dead staining with calcein (green) and propidium idiode (red). Viability of 
MDAs within scaffolds was not adversely affected by compressive loading. Bar = 500 pm (inset 
= 100 pm). (D) Total DNA content per scaffold as measured via fluorimetric analysis and (E) 
relative gene expression of Runx2 as determined via qPCR following 3 days of loading. DNA 
content was similar between MDAs in both loaded and nonloaded (NL) scaffolds, while Runx2 
expression was reduced 35% in loaded cultures.
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Table 1: Primers used for qPCR and their expression in loaded groups relative to nonloaded 
groups. Other than Runx2 expression, changes in other gene expression of loaded groups were 
not significant compared to their respective non-loaded groups.
G ene N am e
Fold expression  
norm alized  to NL
Runx2 runt related transcription factor 2 0.68+0.1
RANK Receptor Activator o f  Nuclear Factor k  B 0.87±0.1
DKK1 dickkopf 1 homolog 1.15±0.2
OPN Osteopontin 1.20+0.6
IL-8 interleukin 8 1.06+1.0
MMP1 matrix metalloproteinase 1 0.85+0.1
CXCR4 chemokine (C-X-C motif) receptor 4 1.32+0.6
Actb beta-actin reference gene
Tumor-Associated BM-MSCs Response to Mechanical Loading
To observe the effect of metastatic cancer cell secretions on the loading-response of BM- 
MSCs, I applied mechanical stimuli for 3 days in the presence of tumor-soluble factors (TCM). 
Similar to MDAs, BM-MSCs proliferation was not affected by mechanical loading (Fig. 9A) or 
by the presence of tumor-secreted factors (data not shown). I also examined the effect of 
mechanical loading and TCM on changes in gene expression in BM-MSCs. With loading, the 
expression of Runx2 was increased by 42% compared to those of control (Fig. 9B). The 
expression of SDF-1 and osteocalcin was not significantly different between loaded and 
nonloaded groups. Taken together, these results suggest that BM-MSCs have increased 
osteoblastic activity with loading in the presence of tumor-secreted factors.
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Fig. 9: Effect of loading on BM-MSCs cultured with TCM. (A) Total DNA content per scaffold 
as measured via fluorimetric analysis and (E) relative gene expression of Runx2 as determined 
via qPCR following 3 days of loading. DNA content was similar between BM-MSCs in both 
loaded and nonloaded (NL) scaffolds, while Runx2 expression was increased 42% in loaded 
cultures. * Main effect of loading (vs. NL group).
Discussion
In this study, I examined breast cancer bone metastasis in two different 
microenvironmental settings: first, primary breast cancer cell-microcalcification interactions in 
the breast microenvironment; second, metastatic breast cancer cell-loading interactions in the 
bone microenvironment. I showed that bone-marrow derived stem cells (BM-MSCs) are capable 
of forming microcalcifications under the influence of breast cancer cell secretions. I also showed 
that mechanical loading reduced the expression of Runx2, a modulator of breast cancer bone 
metastasis. These results will help uncover the underlying mechanisms for breast cancer so 
frequently metastasizing to the skeleton.
When BM-MSCs were cultured with tumor cell-secreted factors, differentiation and 
mineralization was greater with factors from bone-specific breast cancer cells than with those
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from parental or lung-specific breast cancer cells, and this was independent of stem cell passage 
number. One plausible explanation is that while tumors secrete factors that increase osteolytic 
activity, they may also upregulate osteoblastic activity24. With breast cancer that has 
metastasized to the skeleton, however, on balance, they disrupt the bone remodeling process by 
activating osteoclastic more than osteoblastic activity. Tumor-secreted factors may require 
osteoblastic differentiation as an indirect way to stimulate osteoclast formation24. Co-culturing 
pre-osteoblasts and pre-osteoclasts with tumor-secreted factors would directly address this 
question.
My data suggest that bone metastatic breast cancer cells secrete factors that influence 
bone marrow progenitor differentiation into a mineral-producing cell phenotype, and this may be 
the mechanism underlying microcalcification formation in the breast. While this study was not 
sufficient to show the mechanisms of forming microcalcification, it suggests the importance of 
tumor-secreted factors in facilitating mineral formation. Although extensive studies must be done 
before therapeutic targets are identified, further characterization of the cross-talk between breast 
cancer and stromal cells will help explain the high rate of metastasis to the skeleton.
Studies conducted by scientists in the Fischbach lab have shown that bone marrow 
progenitors are recruited to the primary tumor site, which in turn enhances breast cancer 
metastasis to bone (Fischbach lab manuscript in preparation). The studies presented here suggest 
that the recruited bone marrow progenitors deposit minerals upon paracrine interactions with 
native cancer cells. This, in turn, provides a positive feedback loop that, based on our in vitro 
studies of BM-MSCs embedded in mineralized scaffolds, further enhances bone formation that 
could be the microcalcifications that seen in breast cancer patients. Investigating the effects of 
loading on mineral deposition of BM-MSCs in a 3-D tumor model18 may reveal another
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mechanism by which primary breast cancer cells are transformed into bone-homing metastatic 
cells.
When I compared relative differentiation of BM-MSCs based on passage number, I did 
not see a clear pattern. I expected to observe decreased differentiation and mineralization of BM- 
MSCs with later passages because murine bone marrow-derived mesenchymal stem cells had 
been shown to exhibit decreasing osteogenic capacity with later passages (p6 vs. pi)40. Here, I 
compared three consecutive passage numbers (p4-p6), and it is possible that the relative 
differentiation capacity of BM-MSCs at these later passages is not as significantly different as 
when comparing pi to p6. Nonetheless, it would be more beneficial and physiologically relevant 
to use even lower passage number cells to observe clinically relevant cancer-stromal stem cell 
interactions41.
My static cultures of BM-MSCs and MDA-MB231 in HA scaffolds suggest an important 
role of HA in cell behavior. BM-MSCs in HA scaffolds showed significantly higher ALP 
activity than those in control scaffolds independent of inducing factors, suggesting that HA alone 
stimulates osteogenic differentiation of BM-MSCs. As expected, this effect was further elevated 
with inducing factors, which increased ALP, collagen and mineral deposition, and osteocalcin 
expression by BM-MSCs. Cell characteristics from the 3-D BM-MSCs differentiation study are 
consistent with in vivo osteoblastic behavior and clearly support my hypothesis that our 3-D 
mineralized model is appropriate for recapitulating the bone microenvironment. As for the 
response of tumor to the mineralized environment, MDA-MB231 in HA scaffolds increased 
expression of soluble factors related to the formation of osteolytic lesions (IL-8)42 and bone- 
metastatic capability (OPN, MMP1, CXCR4)21 compared to PLG scaffolds, indicating that 
mineral could have a role in facilitating breast cancer bone metastasis also (data not shown).
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Over my 60-day differentiation study, the HA scaffolds maintained their architecture both 
in the presence and absence of osteogenic factors. HA scaffolds shrank the least, followed by 
PLG control scaffolds, which were markedly contracted. Since all acellular scaffold types 
maintained their original shape, scaffold contraction was not due to media-related degradation. 
Instead, osteoblasts likely pull on the scaffold matrix and remodel it via enzymatic reactions, 
resulting in contraction. Also, the mineral provides additional mechanical strength, helping 
scaffolds to retain their shape better during the scaffold-cell interaction43. Since PLG scaffolds 
do not contain mineral, however, they could be degrading faster during cell interactions.
To probe the effect of loading on BM-MSCs and MDA-MB231 behavior, I initially 
employed two different loading systems: hydrostatic loading and compressive loading. 
Hydrostatic loading alone did not increase ALP or total protein expression of BM-MSCs 
(Supplementary Fig. 2), thus I next chose a loading system that applies compressive loading to 
the entire scaffold. This type of loading results in both fluid flow shear stress throughout the 
scaffold’s pores and substrate deformation. Physiologically, the skeleton experiences various 
loading modalities simultaneously, but the effects of hydrostatic pressure on bone cells is 
probably negligible relatively to fluid flow and matrix deformation, which typically elicit very 
robust responses35.
My results from in vitro mechanical loading of breast cancer cells suggest that while 
loading itself does not alter tumor cell viability or growth, it may have an effect on expression of 
genes that modulate homeostatic bone remodeling. Bone metastatic breast cancer cells exhibit a 
‘bone metastatic signature’ that includes increased expression of (OPN, MMP1, and CXCR4)21. 
They also highly express genes related osteolytic remodeling (IL-8, RANK, DKK, Runx2)22'27. 
My mechanical loading studies showed no changes in gene expression of the bone metastasis
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signature or of osteolysis, except for reduced Runx2 levels. Runx2 stimulates osteolysis by 
upregulating PTHrP-induced RANK secretion by osteoblasts, which in turn, activates osteoclast 
activity44, and its abolishment minimized osteolysis25. Furthermore, Runx2 also decreased 
osteoblast differentiation by modulating secretion of schlerostin, an inhibitor of Wnt signaling 
(i.e., a major regulatory pathway of skeletal biology)27'28. Both our in vivo and in vitro studies 
suggest that mechanical loading may reduce osteolysis by promoting osteoblastic over 
osteoclastic activity. Further studies are needed to understand how loading-mediated reduction in 
Runx2 expression alters cell signaling pathways that ultimately may reduce breast cancer bone 
metastasis.
Similarly, mechanical loading of BM-MSCs, even in the presence of tumor-secreted 
factors, did not affect cell viability or growth. Early commitment of BM-MSCs to the 
osteoblastic lineage was greatest with loading in the presence of TCM, as determined by 
expression of Runx2, here an indicator of differentiation30'31. Three days of loading was likely 
insufficient to see the changes in osteocalcin expression since it is a marker for late-stage 
osteoblast differentiation32. Taken together, results from our in vitro loading studies suggest that 
secreted factors from MDAs are driving the effects of loading in preventing secondary tumor 
growth and osteolysis in vivo11. A limitation of the current BM-MSCs loading study is that 
tumor-conditioned media was not collected from loaded MDAs. Future work should include 
loaded TCM to fully characterize the effects of loading on tumor cell-secreted factors and their 
role in subsequent bone cell behavior.
Mechanical stimulation is often recommended for patients with pathological bone loss 
(e g., osteoporosis) to maintain or increase the bone mass14. This could be similarly used for 
patients who have metastatic bone disease. Clinically, physical therapy has shown to improve
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patients’ prognosis and quality of life undergoing or recovering from chemotherapy15’45’46. 
However, the specific role of physical stimulation in preventing or treating bone metastatic 
disease or other secondary tumor growth has been unknown. Results from loading breast cancer 
both in vivo17 and in vitro collectively suggest that mechanical loading inhibits pro-osteolytic 
behavior of bone metastatic breast cancer cells. Although further investigation is necessary to 
understand how mechanical stimulation will be translated to the clinic, our results propose a 
potential starting point to consider incorporating physical therapy into treating or preventing 
cancer-associated osteolysis. Physicians often discourage prescribing high-impact exercise -  the 
most effective way of improving bone density47'48 -  to patients with advanced bone metastatic 
disease, as they are more susceptible to skeletal fragility and pain3'5. Therefore, physical therapy 
may be more effective in earlier stages of breast cancer.
My results present a functional link between mechanical loading and breast cancer- 
associated osteolysis, and suggest many interesting future studies. For example, determining 
whether loaded cancer cells in bone become dormant, undergo apoptosis, or metastasize to 
different organs is important for fully understanding the role of loading in metastasis. Using this 
3-D loading model employed here, investigating dormancy and apoptosis could be tested by 
loading MDAs for a longer period of time (e.g., 4 to 6 weeks as done for our in vivo study17). 
Additionally, an altered phenotype under loading may suggest metastasis to other organs. For 
example, expression of genes commonly associated with metastasis to other sites (e.g. lungs, 
liver, brain)49 could be examined (e.g., lung colonization with high expressions of CD44v50, 
COX2, EREG51). Furthermore, it remains unknown whether different magnitudes of 
compression or other loading modalities affect tumor cell behavior. These aspects of mechanical 
loading need to be investigated in order to better understand the underlying mechanisms of
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physical stimuli on primary as well as metastatic tumor sites, and to develop feasible therapy for 
patients prone to skeletal fracture and pain.
Conclusions
Microcalcifications in the primary tumor likely arise from interactions between breast 
cancer and BM-MSCs in the breast microenvironment Additionally, mechanical loading inhibits 
tumor-associated osteolysis in the bone microenvironment by modulating osteoblastic and 
osteoclastic activities in bone remodeling homeostasis rather than by directly affecting tumor cell 
viability. To demonstrate this, I adapted a HA-containing scaffold to create a physiologically 
relevant culture model to study cancer metastasis in bone to which we could apply mechanical 
loading. Further studies are necessary to understand a functional link between the genesis of 
microcalcification and bone metastasis and to fully understand underlying molecular 
mechanisms of what has been seen in vivo. Similarly, studying mechanical loading to suppress 
tumor-associated bone diseases will help explore mechanical stimuli as an important 
microenvironmental parameter for treating bone disease patients.
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Supplemental Table and Figure
Table SI: Primer sequences used for quantitative RT-PCR (qPCR). Gene expressions commonly 
associated with bone metastasis (OPN, MMP1, and CXCR4) and osteolysis (IL-8, RANK, DKK, 
Runx2) were analyzed using qPCR and the comparative ACt method 24 hours after the last 
loading session.
Gene N am e Prim er Sequence
Runx2 runt related transcription factor 2 CCAACCCACGAATGCACTATC Forward
T AGT GAGTGGTGGCGGACATA Reverse
RANK Receptor Activator o f  Nuclear Factor k  B CACCAAATGAACCCCATGTTTAC Forward
GGACTCCTTATCTCCACTTAGGC Reverse
DKK1 dickkopf 1 homolog ATAGCACCTTGGATGGGTATTCC Forward
CTGATGACCGGAGACAAACAG Reverse
OPN Osteopontin TGAGAGCAATGAGCATTCCGATG Forward
CAGGGAGTTTCCATGAAGCCAC Reverse
IL-8 interleukin 8 AGGTGCAGTTTTGCCAAGGA Forward
TTTCTGTGTTGGCGCAGTGT Reverse
MMP1 matrix metalloproteinase 1 AAATGCAGGAATTCTTTGGG Forward
ATGGTCCACATCTGCTCTTG Reverse
CXCR4 chemokine (C-X-C motif) receptor 4 GCCTT ATCCTGCCT GGT ATTGTC Forward
GCGAAGAAAGCCAGGATGAGGAT Reverse
Actb beta-actin AATGTGGCCGAGGACTTTGATTGC Forward
AGG ATGGC AAGGG ACTTCCT GT AA Reverse
38
Scaffold Contraction
HA Control
Scaffold Type
Fig. SI: Scaffold contraction after 60 days of culture with BM-MSCs. Scaffold diameter 
decreased substantially for control scaffolds (-50%, pooled average), whereas HA scaffolds 
maintained their shape after 60 days of culture. * the effect of HA scaffolds vs. PLG 
(comparisons made within and induced and non-induced condition separately).
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Fig. S2: Normalized ALP activity and total protein content assay of lysates prepared from BM- 
MSCs after hydrostatic loading. (A) ALP expression did not increase after 5 days of loading and 
did not show sustained effects of loading after a week (12 days). (B) Loading did not have any 
effect on total protein content of BM-MSCs.
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